Cannabinoid analogs, formulations, and methods of use

A cannabinoid having the structure of formula (EE)

• wherein:
• q1 is zero or 1, and q2 is zero, 1, or 2;
• R11 is selected from C1-C12 hydrocarbyl, substituted C1-C12 hydrocarbyl, heteroatom-containing C1-C12 hydrocarbyl, substituted heteroatom-containing C1-C12 hydrocarbyl, and functional groups, and wherein when n is 2, the R11 may be the same or different and any two R11 bound to adjacent carbon atoms may be taken together to form a cyclic structure selected from a five-membered ring and a six-membered ring, optionally fused to an additional five-membered or six-membered ring, wherein the rings are aromatic, alicyclic, heteroaromatic, or heteroalicyclic, and have zero to 4 non-hydrogen substituents and zero to 3 heteroatoms;
• R12 is H, carboxyl, C2-C6 acyloxy, C2-C6 alkoxycarbonyl, C1-C6 alkyl, or C1-C6 alkyl substituted with hydroxyl, carboxyl, or halo;
• R13 and R14 are independently selected from H, C1-C12 hydrocarbyl, substituted C1-C12 hydrocarbyl, heteroatom-containing C1-C12 hydrocarbyl, substituted heteroatom-containing C1-C12 hydrocarbyl, and functional groups;
• R15 is methyl, hydroxymethyl, or halomethyl;
• and
• R16 is selected from —(CH2)—NHCH3;
• —(CH2)—NHCH2CH3;
• —(CH2)—NH—(CH2)2CH3;
• —(CH2)—NH—(CH2)3CH3;
• —(CH2)2—NHCH3;
• —(CH2)2—NHCH2CH3;
• —(CH2)2—NH—(CH2)2CH3;
• —CH2)2—NH—(CH2)3CH3;
• —(CH2)3—NHCH3;
• —(CH2)3—NHCH2CH3;
• —(CH2)3—NH—(CH2)2CH3;
• —(CH2)3—NH—(CH2)3CH3;
• and —(CH2)3—NH—(CH2)4CH3.